The first three months of pregnancy can feel exciting but also a bit overwhelming—especially when your obstetrician orders multiple tests and scans. The truth is simple: the first trimester is the most crucial phase for your baby’s development, and early screening helps detect problems before they become serious. Early screening helps catch issues at the earliest, safest, and most treatable stage.
It includes a combination of blood tests and an ultrasound (NT scan) done between 11–14 weeks to check the baby’s development and rule out genetic or chromosomal issues.
Each test gives different information:
They help identify issues early so treatment can start on time.
The nuchal translucency (NT) scan measures the thickness at the back of the baby’s neck. It can indicate the risk of Down syndrome and other chromosomal abnormalities, and it also checks:
It’s optional but highly recommended. It combines your blood report with the NT scan to give a more accurate risk estimate for chromosomal problems.
It does not diagnose anything — it only tells us whether your risk is low or high.
Don’t panic. It only means you need further evaluation like NIPT, genetic counselling, or other diagnostic tests such as CVS or amniocentesis.
Most high-risk screening results still turn out normal after further testing.
Yes. All routine first trimester screening tests, including the NT scan and double marker test, are non-invasive and completely safe.
Some tests, like blood sugars, hemoglobin, and thyroid, may need repeat checks.
But the NT scan and double marker test are done only once in the first trimester.
Most first-trimester screening tests are done between 11–14 weeks.
Other routine blood tests (thyroid, CBC, sugars, urine, blood group) can be done anytime in early pregnancy.
If you miss the 11–14 week window:
Don’t worry — we simply switch to the next safest option.
It is recommended for all, but it becomes especially important for:
If you fall in any of these groups, the marker tests help give a clearer picture of the baby’s chromosomal risk.
It’s better not to. These early tests help detect issues at the most treatable stage. Skipping them may delay diagnosis of conditions that could affect you or your baby.
📍 Source: Dr. Shweta Mehta – DNB, Obstetrics & Gynaecology | United Multispeciality Hospital, Kandivali West, Mumbai.